Japan · Delayed Price · Currency is JPY Daiken Medical Statistics
Total Valuation
Daiken Medical has a market cap or net worth of JPY 13.50 billion. The enterprise value is 12.86 billion.
| Market Cap | 13.50B |
| Enterprise Value | 12.86B |
Important Dates
The next estimated earnings date is Friday, January 30, 2026.
| Earnings Date | Jan 30, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Daiken Medical has 28.73 million shares outstanding.
| Current Share Class | 28.73M |
| Shares Outstanding | 28.73M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 48.78% |
| Owned by Institutions (%) | 4.81% |
| Float | 14.46M |
Valuation Ratios
The trailing PE ratio is 13.50.
| PE Ratio | 13.50 |
| Forward PE | n/a |
| PS Ratio | 1.34 |
| PB Ratio | 1.77 |
| P/TBV Ratio | 1.77 |
| P/FCF Ratio | 21.57 |
| P/OCF Ratio | 15.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.07, with an EV/FCF ratio of 20.55.
| EV / Earnings | 12.86 |
| EV / Sales | 1.27 |
| EV / EBITDA | 8.07 |
| EV / EBIT | 9.52 |
| EV / FCF | 20.55 |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.57 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.05 |
| Debt / FCF | 2.67 |
| Interest Coverage | 122.82 |
Financial Efficiency
Return on equity (ROE) is 13.41% and return on invested capital (ROIC) is 14.76%.
| Return on Equity (ROE) | 13.41% |
| Return on Assets (ROA) | 7.60% |
| Return on Invested Capital (ROIC) | 14.76% |
| Return on Capital Employed (ROCE) | 16.30% |
| Weighted Average Cost of Capital (WACC) | 3.95% |
| Revenue Per Employee | 56.08M |
| Profits Per Employee | 5.56M |
| Employee Count | 180 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 4.16 |
Taxes
In the past 12 months, Daiken Medical has paid 345.00 million in taxes.
| Income Tax | 345.00M |
| Effective Tax Rate | 25.65% |
Stock Price Statistics
The stock price has decreased by -6.56% in the last 52 weeks. The beta is 0.02, so Daiken Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | -6.56% |
| 50-Day Moving Average | 446.62 |
| 200-Day Moving Average | 452.13 |
| Relative Strength Index (RSI) | 75.40 |
| Average Volume (20 Days) | 48,245 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Daiken Medical had revenue of JPY 10.09 billion and earned 1.00 billion in profits. Earnings per share was 34.81.
| Revenue | 10.09B |
| Gross Profit | 3.99B |
| Operating Income | 1.35B |
| Pretax Income | 1.35B |
| Net Income | 1.00B |
| EBITDA | 1.59B |
| EBIT | 1.35B |
| Earnings Per Share (EPS) | 34.81 |
Balance Sheet
The company has 2.31 billion in cash and 1.67 billion in debt, with a net cash position of 638.00 million or 22.21 per share.
| Cash & Cash Equivalents | 2.31B |
| Total Debt | 1.67B |
| Net Cash | 638.00M |
| Net Cash Per Share | 22.21 |
| Equity (Book Value) | 7.63B |
| Book Value Per Share | 265.42 |
| Working Capital | 4.00B |
Cash Flow
In the last 12 months, operating cash flow was 860.00 million and capital expenditures -234.00 million, giving a free cash flow of 626.00 million.
| Operating Cash Flow | 860.00M |
| Capital Expenditures | -234.00M |
| Free Cash Flow | 626.00M |
| FCF Per Share | 21.79 |
Margins
Gross margin is 39.49%, with operating and profit margins of 13.38% and 9.91%.
| Gross Margin | 39.49% |
| Operating Margin | 13.38% |
| Pretax Margin | 13.32% |
| Profit Margin | 9.91% |
| EBITDA Margin | 15.79% |
| EBIT Margin | 13.38% |
| FCF Margin | 6.20% |
Dividends & Yields
This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 4.26%.
| Dividend Per Share | 20.00 |
| Dividend Yield | 4.26% |
| Dividend Growth (YoY) | -13.04% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 66.90% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.30% |
| Earnings Yield | 7.41% |
| FCF Yield | 4.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 13, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Nov 13, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Daiken Medical has an Altman Z-Score of 5.47 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.47 |
| Piotroski F-Score | 6 |